Our data indicated that miR‐612 targeted NOB1 to inhibit cervical cancer cell proliferation, migration and invasion and induce apoptosis in vitro, while also suppressing tumour growth in vivo. This evidence concerns the gene NOB1 and cervical carcinoma.